GlassScriptPhysician profile
Andrew D Cooper
NPI 1093154023
$3,329.56
in general payments reported to CMS, 2019-2025
13 companies · $156 in 2025
The $156 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $242 · 2021: $139 · 2022: $309 · 2023: $283 · 2024: $2,047 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,409 · Food and Beverage: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,409.10 |
| Food and Beverage | $1,077.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,788.76 | 2024-2025 | Intracept |
| Abbvie INC. | $824.00 | 2021-2025 | Ubrelvy, Qulipta |
| Allergan, INC. | $204.37 | 2019-2022 | |
| Nevro Corp. | $163.87 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $107.52 | 2019-2025 | Ajovy |
| Stimwave Technologies Incorporated | $86.48 | 2020-2021 | |
| Smith+Nephew, INC. | $52.88 | 2025 | Pico 7 |
| Ipsen Biopharmaceuticals, INC | $22.68 | 2023 | Dysport |
| Ferring Pharmaceuticals INC. | $18.85 | 2019 | |
| Piramal Critical Care | $17.26 | 2023 | |
| Bioventus LLC | $15.49 | 2024 | Durolane |
| Nalu Medical, INC. | $14.91 | 2024 | Nalu Neurostimulation System |
| Biohaven Pharmaceutical Holding Company LTD. | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.